NASDAQ: EXAS 58.87
Change: +0.37 +0.63% Minimum 20 min delay
3:59 PM ET on Nov 17, 2017
Volume: 986,192

OUR FIRST MISSION:

To work with patients, payers & providers to help play a role in the eradication of colorectal cancer.

Exact Sciences Laboratories

How our lab’s technologies and efficiencies carry Cologuard from arrival to result.

The Exact Science of Customer Care

Supporting patients and driving compliance is a science all its own. Learn how we practice it.

Tennis Anyone?

How Cologuard's keeping Steve Rubin on the court and bringing physicians into play.

Latest Financial Reports

Current Corporate Presentation

Corporate Presentation - Fourth Quarter 2017 November 1, 2017
Download (PDF 934 KB)